By editor
Originally published on Tue February 7, 2012 12:53 pm
Transcript
LYNN NEARY, HOST:
Late last summer, Mary Elizabeth Williams got some devastating news: her cancer had returned. A year after recovering from malignant melanoma on her scalp, it had resurfaced, this time in her lungs and back. News can't get much worse than that, but then Williams learned that the FDA had recently approved clinical trials for first new melanoma drug in decades. She qualified for the trial several months ago and has been writing about her experiences for Salon. Mary Elizabeth Williams joins us in a moment.
Read more